End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.14 BGN | +0.99% | +0.99% | +7.34% |
Feb. 29 | Sopharma AD Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Sopharma AD Reports Sales Results for the Month and Eleven Months Ended November 2023 | CI |
Sales 2024 * | 1.99B 1.1B | Sales 2025 * | - | Capitalization | 1.02B 564M |
---|---|---|---|---|---|
Net income 2024 * | 72M 39.96M | Net income 2025 * | - | EV / Sales 2024 * | 0.51 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
13.3
x | P/E ratio 2025 * |
-
| Employees | 4,721 |
Yield 2024 * |
4.89% | Yield 2025 * |
-
| Free-Float | 30.85% |
1 day | +0.99% | ||
1 week | +0.99% | ||
Current month | +1.99% | ||
1 month | +3.02% | ||
3 months | +1.66% | ||
6 months | -14.72% | ||
Current year | +7.34% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 40 | 00-09-30 | |
Director of Finance/CFO | - | 01-12-31 | |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 40 | 00-09-30 | |
Bisera Lazarova
BRD | Director/Board Member | - | - |
Director/Board Member | 61 | 99-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 6.14 | +0.99% | 3,315 |
24-05-22 | 6.08 | -0.65% | 6,247 |
24-05-21 | 6.12 | 0.00% | 3,750 |
24-05-20 | 6.12 | +0.66% | 8,460 |
24-05-17 | 6.08 | +1.67% | 5,176 |
End-of-day quote Bulgaria S.E., May 22, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.34% | 562M | |
-38.61% | 13.83B | |
-31.33% | 10.96B | |
+13.51% | 6.34B | |
-8.33% | 6.08B | |
-30.66% | 6.05B | |
+72.00% | 4.98B | |
-1.75% | 4.67B | |
-4.84% | 4B | |
-16.14% | 3.28B |
- Stock Market
- Equities
- SFA Stock